Experienced in Neurohypophyseal Diabetes Insipidus

Kathleen De Waele

Universitair Ziekenhuis Leuven
Leuven, VLG, BE 
Experienced in Neurohypophyseal Diabetes Insipidus
Universitair Ziekenhuis Leuven
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Kathleen De Waele practices in Leuven, Belgium. Ms. De Waele is rated as an Experienced expert by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. Her top areas of expertise are Precocious Puberty, Neurohypophyseal Diabetes Insipidus, Familial Hypercholesterolemia, and Osteomalacia.

Her clinical research consists of co-authoring 20 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Neurohypophyseal Diabetes Insipidus.

Gender
Female

Locations

Universitair Ziekenhuis Leuven
Leuven, VLG, Belgium
Other Locations
Gent, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Early Onset POMC Deficiency Obesity Due to Bi-Allelic Loss-of-Function POMC or PCSK1 Genetic Mutation
An Open-Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Early Onset POMC Deficiency Obesity Due to Bi-Allelic Loss-of-Function POMC or PCSK1 Genetic Mutation
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3

20 Total Publications

Near Adult Height and Body Mass Index Changes in Growth Hormone Treated Short Children with Noonan Syndrome: The Belgian Experience.
Near Adult Height and Body Mass Index Changes in Growth Hormone Treated Short Children with Noonan Syndrome: The Belgian Experience.
Journal: Hormone research in paediatrics
Published: December 18, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. De Waele's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile